iSERA Lifesciences Limited (BOM:534920)

iSERA Lifesciences Revenue

In the fiscal year ending March 31, 2026, iSERA Lifesciences had annual revenue of 14.25M INR with 437.41% growth. iSERA Lifesciences had revenue of 12.20M in the quarter ending March 31, 2026, with 359.84% growth.

• Revenue: 14.25M
• Revenue Growth: +437.41%
• P/S Ratio: 45.72
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 651.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	14.25M	11.60M	437.41%
Mar 31, 2025	2.65M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error